Carson Wealth (CWM LLC)
XENE icon

Carson Wealth (CWM LLC)’s Xenon Pharmaceuticals XENE Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.7K Buy
510
+144
+39% +$6.63K ﹤0.01% 4171
2025
Q4 		$16K Buy
366
+31
+9% +$1.3K ﹤0.01% 4314
2025
Q3 		$13K Buy
335
+98
+41% +$3.45K ﹤0.01% 4372
2025
Q2 		$7K Sell
237
-2
-0.8% -$65 ﹤0.01% 4496
2025
Q1 		$8K Buy
239
+181
+312% +$6.87K ﹤0.01% 4245
2024
Q4 		$2K Buy
58
+44
+314% +$1.82K ﹤0.01% 4628
2024
Q3 		$1K Buy
14
+7
+100% +$282 ﹤0.01% 4746
2024
Q2 		$0 Buy
+7
New +$280 ﹤0.01% 4989

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Carson Wealth (CWM LLC)'s XENE Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Xenon Pharmaceuticals (XENE) stake by 39% in Q1 2026, buying an estimated $6.63K and bringing the position to 510 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4171.

Carson Wealth (CWM LLC) first reported a position in XENE in Q2 2024 and has held it in 8 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • Carson Wealth (CWM LLC) held 510 shares of Xenon Pharmaceuticals worth $29.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 144 Xenon Pharmaceuticals shares in Q1 2026, an estimated $6.63K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4171 holding.
  • Carson Wealth (CWM LLC) first reported a position in Xenon Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.